Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
Contained in the library are leading modulators, each labelled with 38 ADME-Tox and 32 physicochemical and drug-likeness qualities. In addition, each compound is illustrated with its optimal docking poses, affinity scores, and activity scores, giving a complete picture.
Our top-notch dedicated system is used to design specialised libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The procedure entails thorough molecular simulations of the catalytic and allosteric binding pockets, accompanied by ensemble virtual screening that factors in their conformational flexibility. When developing modulators, the structural modifications brought about by reaction intermediates are factored in to optimize activity and selectivity.
Key features that set our library apart include:
partner
Reaxense
upacc
P03915
UPID:
NU5M_HUMAN
Alternative names:
NADH dehydrogenase subunit 5
Alternative UPACC:
P03915; Q34773; Q8WCY3
Background:
NADH-ubiquinone oxidoreductase chain 5, also known as NADH dehydrogenase subunit 5, plays a pivotal role in cellular energy production. As a core component of the mitochondrial membrane respiratory chain Complex I, it facilitates electron transfer from NADH to ubiquinone, a critical step in the mitochondrial ATP synthesis process.
Therapeutic significance:
The protein is implicated in several mitochondrial disorders, including Leber hereditary optic neuropathy, Leigh syndrome, and Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes syndrome. These conditions underscore the protein's crucial role in mitochondrial function and highlight the potential for targeted therapeutic strategies to mitigate these debilitating diseases.